Edition:
United Kingdom

Beigene Ltd (BGNE.OQ)

BGNE.OQ on NASDAQ Stock Exchange Global Select Market

136.82USD
11 Dec 2018
Change (% chg)

-- (--)
Prev Close
$136.82
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
173,192
52-wk High
$220.09
52-wk Low
$87.32

Select another date:

Thu, Aug 2 2018

Photo

Chinese biotech BeiGene raises $903 million in HK's first secondary listing under new rules: sources

HONG KONG (Reuters/IFR) - Chinese Nasdaq-listed biotech BeiGene Ltd has raised $903 million after pricing its secondary listing in Hong Kong - the first under new exchange rules - near the top of an indicative range, three people close to the deal said on Thursday.

Chinese biotech BeiGene raises $903 million in Hong Kong's first secondary listing under new rules - sources

HONG KONG (Reuters/IFR) - Chinese Nasdaq-listed biotech BeiGene Ltd has raised $903 million after pricing its secondary listing in Hong Kong - the first under new exchange rules - near the top of an indicative range, three people close to the deal said on Thursday.

UPDATE 1-Chinese biotech BeiGene raises $903 mln in HK's first secondary listing under new rules -sources

* Deal is second under new rules for early-stage biotechs (Adds deal details, context)

Chinese biotech BeiGene raises $903 mln in HK's first secondary listing under new rules -sources

HONG KONG, Aug 2 (Reuters/IFR) - Chinese Nasdaq-listed biotech BeiGene Ltd has raised $903 million after pricing its secondary listing in Hong Kong - the first under new exchange rules - near the top of an indicative range, three people close to the deal said on Thursday.

Select another date: